Overview
International law firm McDermott Will & Emery represented Merck (NYSE: MRK), a premier research-intensive biopharmaceutical company, in its launch of the Merck Digital Sciences Studio (MDSS), to enable the generation of innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct investment, access to powerful Azure Cloud computing and opportunities to pilot their technologies in collaboration with discovery and clinical scientists at Merck.
- Following the product launch announcement June 29, 2022, Merck is accepting applications for 12 spots for the first MDSS cohort.
- Todd Finger served as counsel to Merck.
- Read Merck’s press release here.
About McDermott
McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.
